CD274 and neoplasm: Notably, PDAC with intratumoral TLS formation exhibited an enhanced PD-1/PD-L1 pathway, suggesting that vaccine-treated PDAC was converted into an immunogenic tumor, potentially benefitting from anti-PD-1/PD-L1 ICB.